C88.40 Billable / specific Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
ICD-10-CM C88.40 identifies “Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Inclusion terms8
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] NOS
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] with failed remission
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] NOS
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] not having achieved remission
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] with failed remission
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] NOS
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] not having achieved remission
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] with failed remission
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C88 · Malignant immunoproliferative diseases and certain other B-cell lymphomas
C88.4 · Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
Inclusion terms2
- Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma]
- Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma]
Excludes 11
high malignant (diffuse large B-cell) lymphoma (C83.3-)
Official index references
Official conversion history
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: C88.4
History
Code history
Latest recorded change · FY2025
Effective from
- Added
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
Billable diagnosis code
CDC/NCHS · FY2025All editions (5)
| All editions | Effective from | Code history |
|---|---|---|
| FY2025 | 2024-10-01 | Added |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.